Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery

International Journal of Colorectal Disease

Volumn 25, Issue 3, 2010, Pages 401-404

  Bordeianou, Liliana ^a   Kunitake, Hiroko ^a   Shellito, Paul ^a   Hodin, Richard ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Infliximab; Subtotal colectomy; Surgical complications; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; HUMAN ALBUMIN; INFLIXIMAB; MERCAPTOPURINE; STEROID;

ADULT; ARTICLE; COLON PERFORATION; COLON RESECTION; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; ILEOSTOMY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROCTOCOLECTOMY; TOXIC MEGACOLON; ULCERATIVE COLITIS;

ABDOMEN; ADULT; ANTIBODIES, MONOCLONAL; COLECTOMY; COLITIS, ULCERATIVE; COLONIC POUCHES; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; PERIOPERATIVE CARE;

EID: 77649233260     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-009-0800-5     Document Type: Article

References (11)

1. GR Lichtenstein S Yan M Bala M Blank BE Sands 2005 Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease Gastroenterology 128 4 862 869 10.1053/j.gastro.2005.01.048 1:CAS:528:DC%2BD2MXjvV2qtrY%3D 15825070 (Pubitemid 40523539)
2. IJ Mor JD Vogel L Moreira Ada B Shen J Hammel FH Remzi 2008 Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy Dis Colon Rectum 51 8 1202 1207 10.1007/s10350-008-9364-7 1:STN:280:DC%2BD1cvnslCitA%3D%3D 18536964 discussion 1207-1210
3. CR Selvasekar RR Cima DW Larson, et al. 2007 Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis J Am Coll Surg 204 5 956 962 10.1016/j.jamcollsurg.2006.12.044 17481518 discussion 962-953 (Pubitemid 46661200)
4. S Galandiuk 2007 Discussion J Am Coll Surg 204 962 10.1016/j.jamcollsurg. 2006.09.021 (Pubitemid 46001600)
5. WH Hall R Ramachandran S Narayan AB Jani S Vijayakumar 2004 An electronic application for rapidly calculating Charlson comorbidity score BMC Cancer 4 94 10.1186/1471-2407-4-94 15610554 (Pubitemid 40180260)
6. V de Groot H Beckerman GJ Lankhorst LM Bouter 2003 How to measure comorbidity, a critical review of available methods J Clin Epidemiol 56 3 221 229 10.1016/S0895-4356(02)00585-1 12725876 (Pubitemid 36513483)
7. Remicade Package Insert. http://www.remicade.com/remicade/assets/HCP-PPI. pdf
8. P Rutgeerts WJ Sandborn BG Feagan, et al. 2005 Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 23 2462 2476 10.1056/NEJMoa050516 1:CAS:528:DC%2BD2MXhtlShurjE 16339095 (Pubitemid 41770166)
9. GR Lichtenstein S Yan M Bala S Hanauer 2004 Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries Am J Gastroenterol 99 1 91 96 10.1046/j.1572-0241.2003.04010.x 14687148 (Pubitemid 38679108)
10. L Hancock AC Windsor NJ Mortensen 2006 Inflammatory bowel disease: the view of the surgeon Colorectal Dis 8 Suppl 1 10 14 10.1111/j.1463-1318.2006. 00986.x 16594958
11. SJ Schluender A Ippoliti M Dubinsky, et al. 2007 Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis? Dis Colon Rectum 50 11 1747 1753 10.1007/s10350-007-9008-3 17704969 (Pubitemid 350077092)